This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Last weekend, researchers gathered in San Diego for the American Academy of Neur...
Alzheon’s controversial, decade-long bet that a failed Alzheimer’s drug could of...
Biopharma companies with pending applications at the FDA have "already encounter...
A trial of an AI chatbot built for mental health treatment has shown that it can...
A biotech incubated by RA Capital has secured a $57.5 million Series B to begin ...
HHS and 19 other government agencies can follow through with firing thousands of...
The nonprofit drug pricing watchdog, the Institute for Clinical and Economic Rev...
It’s a biotech environment without many good choices. Even before President ...
Plus, news about Vincerx and Cytora: Idorsia’s Tryvio gets safety restrictio...
Novo Nordisk is pouring 6.4 billion Brazilian reais ($1.05 billion) into a facto...
President Donald Trump warned on Tuesday evening that “major” pharmaceutical tar...
Executives of major pharmaceutical companies warned the European Union that they...
The state of the US biosimilar market isn't as healthy as it should be despite s...
The Trump administration on Tuesday said it will challenge a federal judge’s ord...
The markets have been volatile over the past few days, turned upside down by the...